Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Integra's Flowable Wound Matrix Receives CE Mark Certification

RELATED NEWS
Trade IART now with 

Integra LifeSciences Holdings Corp. (IART: Quote) Friday said it has received European CE Mark Certification for its Integra Flowable Wound Matrix, a device used for filling deep soft tissue or tunneling wounds in patients suffering from diabetes.

The device has been recognized by surgeons as one of the most innovative new products available for the management of chronic wounds in diabetic patients, thereby lowering the risk of amputation.

French Society of Reconstructive and Esthetic Plastic Surgery has awarded Integra's Flowable Wound Matrix 1st place in its innovation contest.

Approximately 55 million people in the European Union suffer from diabetes, of which an estimated 3 million will develop a foot ulcer.

Click here to receive FREE breaking news email alerts for Integra Lifesciences Holdings Corp and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.